them with the only chance for long-term survival. In up to 45% of resectable cases, an extended hepatectomy is necessary to achieve a clear resection margin, a major determining factor for long-term survival.
1,2 It is generally agreed that the future liver remnant (FLR) must be at least 25% to 30% of the liver volume to overcome problems related to liver insufficiency in patients with a healthy liver. This leaves only 10% to 20% of patients suitable for surgery at presentation.
Over the years, various methods have been used clinically to induce hypertrophy of the FLR preoperatively, with the aim of reducing postoperative complications and increasing the proportion of patients suitable for resection. Portal vein embolization (PVE) is the standard technique used clinically in patients with insufficient FLR before liver resection and can result in an increase in the FLR volume of 11.9%. 3 Schnitzbauer et al 4 proposed the alternative surgical method of ALPPS, where a much greater increase in the FLR volume of 74% was seen in a much shorter time period. However, the morbidity from this procedure 4-8 is 33% to 64% compared with 16% after PVE. 3 The morbidity after ALPPS is increased because of a high rate of postoperative bile leaks. A group from Buenos Aires tried to reduce the higher risk of biliary leak by wrapping the whole diseased ischemic liver in a hermetic plastic bag. 5 However, their morbidity rate remained high at 58.0%. 6 In Germany, a median hypertrophy rate as high as 87.2% was seen after performing ALPPS in 9 patients; however, the bile leak rate was still 22.2%. 7 In our center, a novel technique has been described by a senior surgeon (L.R.J.) to achieve a rapid increase in FLR within a short period of time, as seen in ALPPS without the increased morbidity rates related to ALPPS, by using in-line radio frequency to create an virtual liver partition with portal vein ligation-Radio-frequencyAssisted Liver Partition with Portal vein ligation (RALPP). In-line radio frequency uses a probe with electrodes in one line and can produce a precise avascular area up to 1 cm wide. Between January and October 2013, 5 patients (3 men, 2 women) with a median age of 62 years (range, 48-71 years) underwent RALPP by L.R.J.
After resection of tumor from the left lobe, for those requiring staged liver resection with bilobar disease, as previously described by our group, 9 attention was paid to hilar dissection for identification and ligation of the right portal vein. The portal vein was carefully separated from the common hepatic duct behind the right hepatic artery. Whenever possible, the right hepatic artery was isolated and slung with a nonabsorbable suture (2/0 Prolene) to aid identification and ligation of this at the second-stage liver resection. The right portal vein was isolated using blunt dissection and ligated using 2 Hem-oloks (Teleflex, Asheboro, NC). After ligation of the right portal vein, the demarcation between the left and right lobes of the liver was clearly visible. Then, radio-frequency ablation with either Cool-tip radio-frequency ablation probe (Covidien, Hampshire, UK) for open case (n = 1) or Habib Sealer (LH4X, Rita) for laparoscopic case (n = 4) was performed for completion of RALPP along the line of the demarcation to segment VIII of the liver above the right hepatic vein superiorly and to segment V above the hilus on the left side of the gallbladder. A 5-port (2 × 10-mm working ports on each side of abdomen) technique was used for laparoscopic operation. All patients had a restaging computed tomographic scan with contrast to assess the liver volume before right hepatectomy.
We also examined a historical cohort of 5 patients who underwent PVE, matched for age, sex, initial liver function, and pathology, and compared the percentage increase in the FLR volume, 90-day morbidity and mortality, time to second operation, and liver function after completion hepatectomy on postoperative days 1 to 5. Liver volumes were calculated using ImageJ (Image Processing and Analysis in Java, National Institutes of Health) as previously described. 10 The FLR was measured as the left lobe of the liver to the left of the Cantlie line.
All patients had a right hepatectomy for colorectal liver metastases after either RALPP (n = 5) or PVE (n = 5). RALPP was performed laparoscopically as planned in 4 patients, as a part of stage I resection for bilobar disease with tumorectomy from segment II (n = 1), segment III (n = 2), and segment IV (n = 1). The median length of operation for these 4 cases was 140 minutes (range, 105-180 minutes). One patient had an open operation for RALPP, as it was felt intraoperatively that her tumor had progressed while waiting for operation and she would require a right hepatectomy to achieve R0 resection for her tumor, but her FLR was inadequate. One patient who had RALPP and a wedge resection of segment II metastases laparoscopically was readmitted a week after discharge with recurrent chest pain. She was known to have multiple pulmonary emboli after her colectomy and had had an inferior vena cava filter inserted. Although it was unclear whether she had a new or old pulmonary embolus, she was treated with intravenous heparin. There was no other morbidity in RALPP group. In the PVE group, one patient developed a large pleural effusion posthepatectomy requiring drainage. No patients developed a postoperative bile leak in either group. There was no mortality at 90 days.
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RALPP could significantly increase the FLR by a median of 62.3% (range, 53.1%-95.4%) in a much shorter length of time (mean = 21.8 ± 9.4 days) than by PVE, which increased the FLR by a median of 24.6% (range, 8.4%-35.4%) after 55.4 ± 15.6 days, reflecting a significant gain of FLR by 38.0% (P = 0.0079) with a significant reduction of 34 days to achieve this (P = 0.003) (Figs. 1, 2) . There was no difference in liver function between the 2 groups on days 1 to 5 posthepatectomy.
ALPPS is superior to PVE in terms of FLR but is associated with a greater morbidity and mortality, particularly from bile leaks and hemorrhage after the initial procedure. [4] [5] [6] [7] [8] In the current RALPP study, a high hypertrophy rate of 62.3%, similar to ALPPS, 4, 5 was achieved with no mortality and a morbidity rate of 20.0%. No bile leaks were seen in patients on liver resection after RALPP. The hypertrophy rate is far greater than that reported in PVE studies and, indeed, in this case-controlled study, where the FLR was analyzed with the same method of volume calculation. The physiological mechanism for this greater increase in FLR is not known but may be in response to surgical trauma and a complete transection of the parenchyma, thereby stopping any cross-portal circulation. Both these mechanisms may create a regeneration stimulus. The rapid regeneration response of a mean of 21.8 days in our study and 9 days in the original ALPPS article has certain benefits. 5 Importantly, there is less time for additional micro-and macro-metastatic diseases to develop. Indeed, in 12.0% of patients, hepatic resection after PVE is not possible due to tumor progression, 3 thought to FIGURE 1. The percentage increase in the size of the FLR after both RALPP and PVE (median, error bars depict the range). * * P = 0.0079, calculated using the MannWhitney U test.
FIGURE 2.
The number of days between either RALPP or PVE and completion hepatectomy (median, error bars depict the standard deviation. * * P = 0.003, calculated using the Student t test (2-tailed).
be due to a more rapid growth of tumor than liver parenchyma after PVE. 11 Whether this is significantly improved with ALPPS must be determined in an awaited clinical trial. The major drawback to ALPPS is the high morbidity rate, in particular from bile leaks, and an increased mortality rate. We believe that RALPP is a better alternative than ALPPS because it limits the invasiveness of the first stage of the procedure while capitalizing on the liver hypertrophy without high morbidity and mortality rates associated with ALPPS. It can easily be performed laparoscopically and can be performed at the same time as a stage 1 liver resection for patients with bilobar disease.
Although only 5 patients were reported here who had undergone RALPP, it has been demonstrated that it is a feasible and safe alternative to ALPPS to achieve a rapid liver regeneration in the contralateral lobe of the liver without the increased morbidity and mortality associated with ALPPS. We are setting up a randomized controlled trial to further evaluate the technique compared with PVE and ALPPS.
